Cephalosporin resistant Escherichia coli from cancer patients in Cairo, Egypt

Microbiology and Immunology

Volumn 57, Issue 5, 2013, Pages 391-395

  Abdelaziz, Mohammed O ^a   Bonura, Celestino ^b   Aleo, Aurora ^b   Fasciana, Teresa ^b   Calà, Cinzia ^b   Mammina, Caterina ^b  

^a Helwan   (Egypt)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cancer patients; CTX M 15; Escherichia coli; Multidrug resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEMASE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM;

AAC IB CR GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLACTX M 15 GENE; BLAOXA 48 GENE; CANCER PATIENT; EGYPT; ESCHERICHIA COLI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NOTE; PHENOTYPE; PHYLOGENY;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA, BACTERIAL; EGYPT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; GENOTYPE; HUMANS; MOLECULAR TYPING; NEOPLASMS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84877888017     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12046     Document Type: Note

References (18)

1. Burke L., Humphreys H., Fitzgerald-Hughes D. (2012) The revolving door between hospital and community: extended-spectrum β-lactamase-producing Escherichia coli in Dublin. J Hosp Infect 81: 192-198.
2. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Cantón R., Nordmann P. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 14: 195-200.
3. Courpon-Claudinon A., Lefort A., Panhard X., Clermont O., Dornic Q., Fantin B., Mentré F., Wolff M., Denamur E., Branger C., Group C.O.L.I.B.A.F.I. (2011) Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 17: 557-565.
4. Vigil K.J., Adachi J.A., Aboufaycal H., Hachem R.Y., Reitzel R.A., Jiang Y., Tarrand J.J., Chemaly R.F., Bodey G.P., Rolston K.V., Raad I. (2009) Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 37: 741-745.
5. Cao X., Cavaco L.M., Lv Y., Li Y., Zheng B., Wang P., Hasman H., Liu Y., Aarestrup F.M. (2011) Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. J Clin Microbiol 49: 2496-2501.
6. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. (2009) Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22: 664-689.
7. Mohamed Al-Agamy M.H., El-Din Ashour M.S., Wiegand I. (2006) First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 27: 545-548.
8. Fam N., Leflon-Guibout V., Fouad S., Aboul-Fadl L., Marcon E., Desouky D., El-Defrawy I., Abou-Aitta A., Klena J., Nicolas-Chanoine M.H. (2011) CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 17: 67-73.
9. Clinical and Laboratory Standards Institute. (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. P Wayne, PA: CLSI.
10. Clermont O., Bonacorsi S., Bingen E. (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-8.
11. Lau S.H., Cheesborough J., Kaufmann M.E., Woodford N., Dodgson A.R., Dodgson K.J., Bolton E.J., Fox A.J., Upton M. (2010) Rapid identification of uropathogenic Escherichia coli of the O25 H4- ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system. Clin Microbiol Infect 16: 232-237.
12. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G. (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65: 490-495.
13. Chihara S., Okuzumi K., Yamamoto Y., Oikawa S., Hishinuma A. (2011) First case of New Delhi metallo-β-lactamase 1-producing Escherichia coli infection in Japan. Clin Infect Dis 52: 153-154.
14. Poirel L., Potron A., De La Cuesta C., Cleary T., Nordmann P., Munoz-Price L.S. (2012) Wild coastline birds as reservoirs of broad-spectrum-β-lactamase-producing Enterobacteriaceae in Miami Beach, Florida. Antimicrob Agents Chemother 56: 2756-2758.
15. Mantengoli E., Luzzaro F., Pecile P., Cecconi D., Cavallo A., Attala L., Bartoloni A., Rossolini G.M. (2011) Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options. Clin Infect Dis 52: 690-691.
16. Poirel L., Bernabeu S., Fortineau N., Podglajen I., Lawrence C., Nordmann P. (2011) Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob Agents Chemother 55: 4937-4938.
17. Mushtaq S., Irfan S., Sarma J.B., Doumith M., Pike R., Pitout J., Livermore D.M., Woodford N. (2011) Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 66: 2002-2005.
18. El Kholy A., Baseem H., Hall G.S., Procop G.W., Longworth D.L. (2003) Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J Antimicrob Chemother 51: 625-630.